Breast cancer<unk>  is used in the treatment and prevention of breast cancer in women. The Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial was of localized breast cancer and women received either<unk> , the selective estrogen receptor modulator tamoxifen, or both for five years, followed by five years of follow-up. After more than 5 years the group that received<unk>  had better results than the tamoxifen group. The trial suggested that<unk>  is the preferred medical therapy for postmenopausal women with localized estrogen receptor-positive breast cancer. Early puberty<unk>  is used at a dosage of 0.5 to 1 mg/day in combination with the antiandrogen bicalutamide in the treatment of peripheral precocious puberty, for instance due to familial male-limited precocious puberty (testotoxicosis) and McCune–Albright syndrome, in boys. Available forms<unk>  is available in the form of 1 mg oral tablets. No alternative forms or routes are available.
Anastrozole
Tamoxifen
Letrozole
Endoxifen
Salvestrol
Norendoxifen
Goserelin
N-Desmethyltamoxifen